Sabrina Rajendran, MD | |
3200 Highland Ave, Downers Grove, IL 60515-1223 | |
(630) 737-7559 | |
(630) 737-8144 |
Full Name | Sabrina Rajendran |
---|---|
Gender | Female |
Speciality | Preventive Medicine - Occupational Medicine |
Location | 3200 Highland Ave, Downers Grove, Illinois |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023118346 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083X0100X | Preventive Medicine - Occupational Medicine | 036092876 (Illinois) | Primary |
Mailing Address | Practice Location Address |
---|---|
Sabrina Rajendran, MD 3200 Highland Ave, Downers Grove, IL 60515-1223 Ph: (630) 737-7559 | Sabrina Rajendran, MD 3200 Highland Ave, Downers Grove, IL 60515-1223 Ph: (630) 737-7559 |
News Archive
Diagnosis of celiac disease is based on a characteristic enteropathy in an intestinal biopsy and evidence that these changes are gluten-triggered. The appropriate use of simpler and more accurate tools would add reliability to the diagnosis of celiac disease. Thus, the celiac disease-related serology might have a key role in defining new diagnostic standards for celiac disease.
Discovering how infections during pregnancy, such as COVID-19 and influenza, can lead to psychiatric illness and developmental disorders in offspring years later, and how to detect, prevent or treat these disorders, is the subject of a $15.7 million grant from the National Institute of Mental Health to the Conte Center at the University of California, Davis.
Crystal L. Haynes, Chief Executive Officer at Saint Louis University Hospital, will be honored as a recipient of a Patriot Award from the Employee Support of the Guard and Reserve (ESGR), a staff organization within the U.S. Department of Defense. The
Researchers report an inverse association between people's subjective social status (SSS) and the likelihood of them having a psychiatric disorder.
Anthera Pharmaceuticals, Inc., today announced financial results and operational update for the third quarter ended September 30, 2014.
› Verified 2 days ago